Emergence of multidrug-resistant Salmonella enterica serovar typhi in Korea by 김현숙 et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 2004, p. 4130–4135 Vol. 48, No. 11
0066-4804/04/$08.000 DOI: 10.1128/AAC.48.11.4130–4135.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Emergence of Multidrug-Resistant Salmonella enterica Serovar Typhi
in Korea
Kyungwon Lee,1,2 Dongeun Yong,1 Jong Hwa Yum,3 Young Sik Lim,3 Hyun Sook Kim,1
Bok Kwon Lee,4 and Yunsop Chong1*
Department of Laboratory Medicine,1 Research Institute of Bacterial Resistance,2 and Brain Korea 21 Project for
Medical Sciences,3 Yonsei University College of Medicine, and National Institute of Health,4 Seoul, Korea
Received 22 December 2003/Returned for modification 29 March 2004/Accepted 14 July 2004
A chloramphenicol-resistant strain of Salmonella enterica serovar Typhi was first noted in Korea in 1992,
when a resistant isolate was detected in a returned traveler. Continued isolation of multidrug-resistant (MDR)
strains thereafter in other settings prompted a retrospective analysis of laboratory records and phenotypic and
genotypic analyses of 12 chloramphenicol-resistant isolates. Among these, one isolate was resistant only to
chloramphenicol, and the other isolates were also resistant to ampicillin and co-trimoxazole. MDR was
transferred by conjugation from 9 of the 11 isolates. PCR showed that all isolates had an incompatible group
HI1 plasmid, and oriT was detected in 10 isolates, which included strains with an unsuccessful transfer of
resistance. All of the ampicillin-resistant isolates had a -lactamase band of pI 5.4 and blaTEM alleles. A PCR
amplicon from an isolate showed that the sequences were identical to those of blaTEM-1, suggesting that all
isolates had a TEM-1 -lactamase. All isolates had class 1 integrons: 10 isolates had integrons of ca. 1.2 kb
with dhfr7 gene cassettes, and 1 isolate had an integron of ca. 2.3 kb with aacA4 and blaOXA-1-like gene cassettes.
The pulsed-field gel electrophoresis patterns of 7 of 11 MDR isolates were identical and indistinguishable from
those reported for isolates in India and Indonesia. In conclusion, some of the MDR strains in Korea are related
to those in other Asian countries. Susceptibility testing became necessary for selection of antimicrobial agents
for the optimal treatment of patients with the emergence of MDR Salmonella serovar Typhi in Korea.
Typhoid fever, a systemic infectious disease caused by Sal-
monella enterica serovar Typhi, affected an estimated 16 mil-
lion people in the 1990s, with 600,000 deaths reported annually
worldwide (10). It has become a rare imported disease in
developed countries (9), but massive outbreaks still occur in
some countries, as was shown in Tajikistan due to the con-
sumption of contaminated municipal water (17). The rate of
typhoid fever in Korea has decreased markedly over the last
decade, but sporadic cases and small outbreaks still occur.
Antimicrobial therapy is generally not required for the treat-
ment of gastrointestinal infections caused by nontyphoidal Sal-
monella strains. However, effective antimicrobial therapy is
required for typhoid fever to reduce morbidity and mortality
(18). Historically, the drugs of choice were chloramphenicol,
ampicillin, and trimethoprim-sulfamethoxazole (co-trimox-
azole). However, antimicrobial-resistant Salmonella serovar
Typhi isolates emerged in the 1970s in Latin America (21) and
Asia (3). A large number of Salmonella serovar Typhi strains
have been isolated in Korea, but no resistant strain was docu-
mented until 1992, when a chloramphenicol-, ampicillin-, and
co-trimoxazole-resistant strain was isolated from a patient who
returned from a Southeast Asian country (K. Lee, D. Yong,
J. H. Yum, Y. S. Lim, Y. Chong, and B.-K. Lee, Abstr. 43rd
Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-865,
2003). We isolated two additional multidrug-resistant (MDR)
strains in 1995, and subsequently, Shin et al. (27) reported a
chloramphenicol resistance rate of 15% among isolates in Ko-
rea in 1997.
MDR Salmonella serovar Typhi isolates commonly harbor a
plasmid of incompatibility group HI1. A 365-bp region of the
RepHI1A region was detected in MDR strains of Salmonella
serovar Typhi isolated in India (26). oriT is located within the
Tra1 region of the plasmid and contains the nic site, which is
one of many genes required for conjugative transfer of IncHI1
plasmid (12). The emergence of MDR Salmonella serovar
Typhi in Korea was possibly due to the acquisition of the
resistance by endemic strains from other resistant gram-nega-
tive bacilli or to the spread of resistant strains from other
countries to which there had been recent increases in interna-
tional travel. To verify these assumptions, comparisons of the
phenotypic and genotypic characteristics of both our suscepti-
ble and our resistant isolates are required.
The aims of this study were to analyze retrospectively the
trends in the isolation and susceptibilities of Salmonella sero-
var Typhi strains from stool specimens at a Korean hospital
and to determine the phenotypic and genotypic characteristics
of recent isolates of chloramphenicol-resistant Salmonella se-
rovar Typhi strains, including the first three strains isolated.
MATERIALS AND METHODS
Isolation and antimicrobial susceptibility trends for Salmonella serovar Typhi.
Stool culture data obtained from 1969 to 1998 at a medical college-affiliated
hospital in Seoul, Korea, were used for retrospective analysis. During that pe-
riod, the methods of isolation and identification of Salmonella serovar Typhi
remained essentially similar and were based on conventional methods, including
the use of selenite broth, MacConkey agar, and salmonella-shigella agar for
isolation and the use of triple sugar iron agar and other biochemical tests (6).
The O-group antigen was determined by the slide agglutination method with
commercial antisera (Difco, Detroit, Mich.) or antisera produced by the National
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Institute of Health of Korea (NIHK). Antimicrobial susceptibility was deter-
mined with commercial disks (Difco or Becton Dickinson, Cockeysville, Md.) by
the Kirby-Bauer disk diffusion method (2) until the NCCLS method replaced it
in 1978 (20).
Antimicrobial susceptibilities of recent isolates. Strains isolated from 1992 to
1998 were used for the characterization of chloramphenicol-resistant Salmonella
serovar Typhi: three strains were isolated at two hospitals affiliated with a med-
ical college in Seoul, and nine strains were isolated by NIHK. Chloramphenicol-
susceptible isolates (9 and 13 strains isolated in 1989 and 1998, respectively) were
used for comparison. Antimicrobial susceptibility was tested by the agar dilution
method (20). The antimicrobial agents used were ampicillin, cephalothin, tetra-
cycline, and nalidixic acid (Sigma Chemical, St. Louis, Mo.); cefotaxime (Aventis,
Frankfurt, Germany); cefoxitin (Merck Sharp & Dohme, Rahway, N.J.); sulbac-
tam (Pfizer Korea, Seoul, Korea); chloramphenicol (Chong Kun Dang, Seoul,
Korea); sulfamethoxazole and trimethoprim (Dong Wha Pharmaceutical, Seoul,
Korea); and ciprofloxacin (Bayer Korea, Seoul, Korea). Escherichia coli strain
ATCC 25922 was used for quality control.
Conjugation and plasmid preparation. Resistance transfer was tested by an
agar mating method with nalidixic acid-resistant recipient E. coli RG 176. The
plasmid was isolated by the alkaline lysis method (25), and the plasmid size was
estimated by comparing it to those of plasmids from E. coli strain V517 and
Klebsiella pneumoniae ATCC 700603.
PCR. DNAs were extracted by boiling whole cells and were used as templates.
The alleles for blaTEM and the class 1 integron were detected by methods
reported previously (4, 13). A 365-bp region of the RepHI1A replicon was
amplified by PCR, which was based on previous studies (7, 26), with primer
HI1A-F (5-GGT CCA ACC CAT TGC TTT AC-3) and primer HI1A-R
(5-CAC GGA AAG AAA TCA CAA C-3). A 285-bp oriT region was detected
with primer F (5-ATA TGG TAC CGG TTA TTG CTA CTT AAT GCC
GA-3) and primer R (5-ATA TAA GCT TAT CTG ATT CTG ACA TGT
GCG-3) (12). E. coli strains YMC IEF-1 and ATCC 25922 were used as TEM-
1-positive and -negative controls, respectively.
Isoelectric focusing. Bacterial cells were broken by sonication, and the super-
natant was used to determine the isoelectric points of the -lactamases (16).
Electrophoresis was performed with a commercial gel (pI 3 to 10) and a tem-
perature control system (Novel Experimental Technology, San Diego, Calif.).
After electrophoresis, the gel was overlaid with filter paper that had been soaked
in a nitrocefin solution of 0.7 mg/ml. Sonicates of the following control strains,
obtained from A. Bauernfeind (Munich, Germany), were used to determine the
pIs: E. coli YMC IEF-1 (TEM-1, pI 5.4), YMC IEF-3 (TEM-52, pI 6.0), and
Cho-TC (CMY-1, pI 8.0) and K. pneumoniae YMC IEF-4 (SHV-3, pI 7.0) and
YMC IEF-5 (SHV-2, pI 7.6).
Nucleotide sequencing. PCR products were used to analyze the nucleotide
sequences of blaTEM in YMC 95/6/4405S and blaOXA-containing class 1 integrons
in YMC 95/6/4405S and YMC 98/P110N. After electrophoresis of the PCR
products, the DNA was extracted with a gel extraction kit (Qiagen, Hilden,
Germany) and was used for direct sequencing. Both strands were analyzed by the
dideoxy-chain termination method with an ABI 3700 autosequencer (Perkin-
Elmer, Foster City, Calif.).
Pulsed-field gel electrophoresis (PFGE). Agarose-embedded chromosomal
DNAs of Salmonella serovar Typhi were prepared according to the instructions
of the instrument manufacturer (Bio-Rad, Hercules, Calif.). The DNA was
digested with XbaI, and the bands were separated with a CHEF-DR II system
(Bio-Rad). The electrophoresis conditions were as follows: switch times, an
initial 0.5 s and a final 30 s; field strength, 6 V; and run time, 20 h. After
electrophoresis, the gel was stained with ethidium bromide and the band patterns
were compared both visually and by using Uniband/MAP software (UVItec Ltd.,
Cambridge, United Kingdom). The confidence level was set at 2% to show a
similarity of 1.0 for two lanes with visually identical patterns and a similarity of
approximately 0.9 for possibly related patterns (a six-fragment difference), as
recommended by Tenover et al. (28).
Nucleotide sequence accession numbers. The nucleotide sequences reported
in this work have been assigned to the GenBank database under accession
numbers AY245101 (the dhfr7-carrying class 1 integron) and AY348316 (aacA4
and blaOXA-1-like gene carrying the class 1 integron).
RESULTS
Typhoid fever used to be a highly endemic disease in Korea.
The mean annual number of Salmonella serovar Typhi isolates
recovered from stool specimens from 1969 to 1988 at a medical
college-affiliated hospital was more than 40 (Table 1). In the
following two 5-year periods, the mean number of isolates
recovered annually decreased to 8.8 and 2.8, respectively. Dur-
ing the period from 1974 to 1983 at the same hospital, the
annual mean numbers of patients harboring Salmonella sero-
var Typhi and S. enterica serovar Paratyphi A, as determined
from blood cultures, were 217 and 61, respectively (17.2 and
4.8% of all culture-positive patients, respectively). In 1991, the
number of patients at the same hospital whose blood harbored
Salmonella serovar Typhi was 22 (0.6% of culture-positive pa-
tients); and this number then decreased further, but the or-
ganism was still occasionally isolated (data not shown).
Isolation of the first MDR Salmonella serovar Typhi strain in
1992 at one of two hospitals affiliated with a medical college,
from a patient who had returned from a Southeast Asian
country, prompted an analysis of the records. However, among
the 985 strains isolated from 1969 to 1993 at the main hospital
of the same medical college, none were resistant to chloram-
phenicol, ampicillin, or co-trimoxazole. In 1995, we isolated
two more MDR strains from a 52-year-old male patient and a
TABLE 1. Trends in isolation of enteric pathogens from stool specimens at a medical college-affiliated hospital in Seoul and antimicrobial
susceptibilities of Salmonella serovar Typhi isolates
Enteric pathogen
No. (%) of isolates by yeara
1969–1978 1979–1988 1989–1993 1994–1998 Total
Salmonella serovar Typhi 472 (21.8) 469 (12.5) 44 (6.5) 14 (1.5) 999 (13.3)
Salmonella serovar Paratyphi A 18 (0.8) 101 (2.7) 2 (0.3) 1 (0.1) 122 (1.6)
Other Salmonella serovars 504 (23.3) 1,102 (29.4) 436 (63.9) 735 (78.4) 2,777 (36.8)
Shigella spp. 1,039 (47.9) 1,508 (40.2) 37 (5.4) 14 (1.5) 2,598 (34.5)
Yersinia enterocolitica NTb 29 (0.8) 9 (1.3) 9 (1.0) 47 (0.6)
Campylobacter spp. NT 185 (4.9) 101 (14.8) 138 (14.7) 424 (5.6)
Vibrio parahaemolyticus 45 (2.1) 96 (2.6) 20 (2.9) 22 (2.3) 183 (2.4)
Othersc 89 (4.1) 262 (7.0) 33 (4.8) 5 (0.5) 389 (5.2)
Total 2,167 (100) 3,752 (100) 682 (100) 938 (100) 7,539 (100)
a All isolates recovered from 1969 to 1978 were susceptible to ampicillin and chloramphenicol (the isolates were not tested for their co-trimoxazole susceptibilities).
All isolates recovered from 1979 to 1993 were susceptible to ampicillin, chloramphenicol, and co-trimoxazole. Two of 14 (12.8%) isolates recovered from 1994 to 1998
were resistant to the three drugs. The first multidrug-resistant isolate at another hospital, in 1992 which was detected was not included.
b NT, not tested.
c Enteropathogenic E. coli and Plesiomonas shigelloides.
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59-year-old female patient with no history of overseas travel
(Table 1).
The antimicrobial susceptibilities of chloramphenicol-resis-
tant and -susceptible recent clinical isolates were compared.
Among the 12 chloramphenicol-resistant Salmonella serovar
Typhi strains isolated from 1992 to 1998, 11 also showed re-
sistance to ampicillin and co-trimoxazole (Table 2). The ranges
of MICs of nalidixic acid and ciprofloxacin were 4 to 8 and
0.015 g/ml, respectively, for both chloramphenicol-resistant
and -susceptible isolates.
Eleven MDR isolates were tested to determine their char-
acteristics (Table 3). The MDR was transferred en bloc by
conjugation from 9 of 11 isolates to an E. coli recipient. The
conjugative plasmid had a size of ca. 120 MDa. The first MDR
isolate in Korea (strain 1) and another isolate (strain 9) also
had plasmids of similar sizes, but repeated attempts to transfer
the resistance even at 28°C were unsuccessful.
PCR was used to determine the incompatibility group of the
plasmid. A 365-bp region of the RepHI1 A replicon was de-
tected in all 11 isolates, including 2 conjugation-negative iso-
lates. The oriT allele was detected in all isolates except one
(strain 11).
blaTEM alleles were detected in all of the ampicillin-resistant
isolates, and the isolates had bands for a -lactamase of pI 5.4.
A PCR amplicon from an isolate (strain 2) had sequences
identical to those of blaTEM-1. This suggests that all isolates
had the TEM-1 -lactamase. In our study, class 1 integrons
were detected by PCR in all 11 MDR isolates. They were ca.
1.2 kb in 10 isolates and ca. 2.3 kb in 1 isolate. Sequencing of
the 1.2-kb integron from one isolate (strain 2) showed carriage
of a dhfr7 gene cassette (Fig. 1A). The strain carrying a 2.3-kb
integron had a -lactamase band of ca. pI 7.4. Sequencing
showed that the integron carried aacA4, blaOXA-1-like resis-
tance gene cassettes, and a short unknown open reading frame
(Fig. 1B).
The PFGE patterns of XbaI-digested genomic DNA of 12
and 19 chloramphenicol-resistant and -susceptible Salmonella
serovar Typhi isolates, respectively, were compared. The pat-
tern of the first MDR isolate in Korea (type A) was different
from those of the other MDR isolates. The remaining 10 MDR
TABLE 2. Comparison of susceptibilities of chloramphenicol-susceptible and -resistant Salmonella serovar Typhi isolates
Isolate type (yr isolated)a Antimicrobial agent
MIC (g/ml)b Susceptibility (%)c
Range 50% 90% S I R
Chloramphenicol resistant Ampicillin 4–128 128 128 8 0 92
(1992–1998; n  12) Ampicillin-sulbactam 4–32 32 32 8 0 92
Cephalothin 8–16 8 16 56 44 0
Chloramphenicol 32–128 128 128 0 0 100
Co-trimoxazole 0.12/2.28–128/2,432 128/2,432 128/2,432 8 0 92
Tetracycline 2–128 128 128 8 0 92
Chloramphenicol susceptible Ampicillin 0.5–1 0.5 1 100 0 0
(1989–1998; n  21) Ampicillin-sulbactam 0.5–1 0.5 1 100 0 0
Cephalothin 2–8 2 2 100 0 0
Chloramphenicol 4–8 4 4 100 0 0
Co-trimoxazole 0.06/1.14–0.12/2.28 0.06/1.14 0.06/1.14 100 0 0
Tetracycline 1 1 1 100 0 0
a Therapeutically nonrelevant drugs were also included to compare the antibiograms of chloramphenicol-susceptible and -resistant isolates. All of the isolates were
inhibited by 0.12 g of cefotaxime per ml, 0.015 g of ciprofloxacin per ml, and 8 g of nalidixic acid per ml.
b 50% and 90%, MICs at which 50 and 90% of isolates, respectively, are inhibited.
c Abbreviations: S, susceptible, I, intermediate; R, resistant.
TABLE 3. Characteristics of MDR Salmonella serovar Typhi isolates
YMC strain (no.) name Conjugationresult
PCR result for:
-Lactamase pI PFGEtypeoriT IncHIIa Integronb blaTEM
(1) 92/8/5479Y    1.2  5.4 A
(2) 95/6/4405S    1.2c c 5.4 C
(3) 95/12/4248S    1.2  5.4 D
(4) 98/K101N    1.2  5.4 E
(5) 98/O102N    1.2  5.4 C
(6) 98/H103N    1.2  5.4 C
(7) 98/H104N    1.2  5.4 C
(8) 98/H105N    1.2  5.4 C
(9) 98/Y106N    1.2  5.4 C
(10) 98/S109N    1.2  5.4 C
(11) 98/P110N    2.3c  5.4, 7.4 C
a A 365-bp region of the RepHI1A replicon.
b Class 1 integron. Data represent approximate sizes (in kilobases).
c The nucleotides of integrons and blaTEM-1 were sequenced.
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isolates clustered together: the second MDR strain, isolated in
1995 (Fig. 2, lane 3, type C), showed a pattern identical to
those of the seven NIHK strains isolated in 1998 (Fig. 2, lane
6).
One strain that was isolated in 1998 and that was resistant
only to chloramphenicol (type M) clustered together with sus-
ceptible strains isolated in 1989 (types K, L, N, O, and P). All
nine antimicrobial-susceptible strains isolated in 1998 clus-
tered together (types F to I).
DISCUSSION
Until the 1980s typhoid fever was an endemic disease in
Korea and Salmonella serovar Typhi was frequently isolated
from stool specimens (Table 1). Typhoid fever is a serious
systemic infection requiring proper antimicrobial therapy. The
present retrospective analysis showed that antimicrobial-resis-
tant Salmonella serovar Typhi was absent until 1992, when it
was detected in a hospital in Korea (Lee et al., 43rd ICAAC),
although MDR Salmonella serovar Typhi became prevalent in
Southeast Asia (8, 30), the Middle East, and northeastern
Africa (1, 19, 23).
Among the chloramphenicol-resistant Salmonella serovar
Typhi strains isolated in the 1990s, 1 chloramphenicol-resistant
isolate was susceptible to ampicillin and co-trimoxazole, but
the remaining 11 were also resistant to ampicillin and co-
trimoxazole (Table 2). Some of the chloramphenicol-resistant
isolates were either intermediate or resistant to cephalothin or
tetracycline (Table 2), but all 11 MDR isolates were suscepti-
ble to ciprofloxacin and nalidixic acid. Ciprofloxacin is recom-
mended as the drug of choice for the treatment of multidrug-
resistant Salmonella serovar Typhi infections (18). However,
an NIHK study suggested that the clinical failure of empirical
fluoroquinolone treatment might occur, as the nalidixic acid
resistance rate rapidly increased from 3.5% in 2001 to 23.3% in
2002, with resistance detected in 138 and 58 isolates, respec-
tively (data not shown). Low-level fluoroquinolone resistance
can be detected by testing only for nalidixic acid resistance (5).
It is a concern that ceftriaxone remains the only drug of choice
for the treatment of infections due to ampicillin- and fluoro-
quinolone-resistant isolates.
It was reported that most MDR Salmonella serovar Typhi
isolates have a conjugative plasmid of the IncHI1 type. This
plasmid has been implicated as a significant factor in the per-
sistence and reemergence of Salmonella serovar Typhi (11, 19).
The reported sizes of the plasmids were quite variable: 220 and
290 kb in isolates from Bangladesh (8); 91.2 MDa in isolates
from Tehran, Iran (1); and 110 to 120 MDa in isolates from
India (30). The type of -lactamase reported was mostly
TEM-1. Most of our MDR strains also had similar character-
istics: they had a ca. 120-MDa conjugative plasmids of the
IncHI1 type, they transferred MDR en bloc, and they had the
TEM-1 -lactamase. However, a few of our isolates showed
heterogeneity. Repeated attempts to transfer the resistance by
conjugation from the first chloramphenicol-resistant strain iso-
lated in Korea (strain 1 in Table 3) failed, even at 28°C; one
isolate was PCR negative for the oriT allele.
Integrons are a major vehicle for the spread of multiple-
antibiotic resistance (14). Class 1 integrons were detected in all
11 MDR isolates. Their sizes were ca. 1.2 kb in all except one
isolate, in which it was ca. 2.3 kb. The smaller integron con-
tained only a dhfr7 resistance gene cassette, but the larger one
contained aacA4 and blaOXA-1-like gene cassettes (Fig. 1). Ploy
et al. (24) reported that all 18 of their resistant Salmonella
serovar Typhi isolates had class 1 integrons with dfrVII gene
cassettes. Pai et al. (22) reported that an MDR strain isolated
in Korea in 1999 had a class 1 integron with the aacA4b, catB8,
aadA1, dfrA1, and aac(6)-IIa gene cassettes and a novel blaP2
cassette. blaP2 is a carbenicillinase gene. These results ob-
tained from studies performed in Korea indicate the existence
of various -lactamase genes in ampicillin-resistant Salmonella
serovar Typhi isolates.
In a comparison of various molecular characteristics, Ling et
al. (15) reported that isolates obtained in Hong Kong in 1985
to 1997 differed from those obtained in Vietnam in 1989 and
1990. They reported that 37% of the Vietnamese isolates be-
longed to two predominant clones. It was reported that the
PFGE pattern of XbaI-digested genomic DNA of Salmonella
serovar Typhi was stable (29). Interestingly, 7 of our 11 MDR
isolates had identical PFGE patterns (Fig. 2, type C), and that
pattern was also apparently identical to that of the MDR
strains isolated in 1993 and 1994 in India (Fig. 2, lanes 7, 8, and
10, in reference 26) and to that of 1 of 5 Indonesian isolates
recovered in 1992 and 1994 (Fig. 1A, lane 14, in reference 29).
These results indicate that our MDR strains are related to
those in other countries. Ispahani and Slack (9) reported that
from 1980 to 1997 all 21 typhoid fever patients at a hospital in
the United Kingdom were of Asian descent, and some had a
history of travel to Asia. Some of these isolates were MDR
strains. With increasing international travel, the further spread
of MDR strains can be anticipated. Seven of our eight MDR
strains with identical PFGE types were isolated from patients
in five cities in one province, suggesting clonal spread. Routine
antimicrobial susceptibility testing of Salmonella serovar Typhi
isolates became crucial for the optimal treatment of typhoid
fever patients in Korea.
In conclusion, the characteristics of chloramphenicol-resis-
tant strains isolated in Korea from 1992 to 1998 were mostly
similar to those reported for isolates in other countries: they
FIG. 1. Schematic structures of class 1 integrons in multidrug-re-
sistant Salmonella serovar Typhi isolates. (A) The integron in strain
YMC 95/6/4405S contained only one resistance gene cassette, dhfr7
(GenBank accession no. AY245101). (B) The integron in strain YMC
98/P110N contained two resistance gene cassettes, aacA4 and a
blaOXA-1-like cassette (GenBank accession no. AY348316).
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were MDR, carried large conjugative IncHI1 plasmids, had the
TEM-1 -lactamase, and had class 1 integrons. Some strains
had subtle differences in characteristics: the nontransferability
of resistance or an integron with a blaOXA gene cassette. With
the emergence of MDR Salmonella serovar Typhi in Korea,
susceptibility testing became necessary for selection of the
antimicrobial agents that could be used for the optimal treat-
ment of patients.
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